90
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

Some Statistical and Regulatory Issues in the Evaluation of Genetic and Genomic Tests

Pages 539-552 | Received 01 Jul 2003, Accepted 01 Dec 2003, Published online: 02 Feb 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Gregory Campbell & Lilly Q. Yue. (2016) Statistical innovations in the medical device world sparked by the FDA. Journal of Biopharmaceutical Statistics 26:1, pages 3-16.
Read now
Bertrand R Jordan. (2010) Is there a niche for DNA microarrays in molecular diagnostics?. Expert Review of Molecular Diagnostics 10:7, pages 875-882.
Read now
Samir Lababidi. (2007) Challenges in DNA Microarray Studies from the Regulatory Perspective. Journal of Biopharmaceutical Statistics 18:1, pages 183-202.
Read now
Gregory Campbell*. (2007) Statistics in the World of Medical Devices: The Contrast with Pharmaceuticals. Journal of Biopharmaceutical Statistics 18:1, pages 4-19.
Read now

Articles from other publishers (12)

Gregory Campbell, Heng Li, Gene Pennello & Lilly Q. Yue. 2014. Wiley StatsRef: Statistics Reference Online. Wiley StatsRef: Statistics Reference Online 1 32 .
Bertrand R. Jordan. 2014. Transcriptomics in Health and Disease. Transcriptomics in Health and Disease 327 340 .
Donna M. Wolk. 2013. Clinical Laboratory Management. Clinical Laboratory Management 832 848 .
Maria P. Pavlou, Ivan M. Blasutig & Eleftherios P. Diamandis. 2013. Comprehensive Biomarker Discovery and Validation for Clinical Application. Comprehensive Biomarker Discovery and Validation for Clinical Application 334 352 .
Greg Campbell, Lilly Yue, Gene Pennello & Mary Barrick. 2012. Encyclopedia of Biopharmaceutical Statistics, Third Edition. Encyclopedia of Biopharmaceutical Statistics, Third Edition 756 767 .
Bertrand Jordan. 2012. Microarrays in Diagnostics and Biomarker Development. Microarrays in Diagnostics and Biomarker Development 21 27 .
Shein-Chung ChowGreg Campbell, Lilly Q. Yue, Gene Pennello & Mary K. Barrick. 2010. Encyclopedia of Biopharmaceutical Statistics. Encyclopedia of Biopharmaceutical Statistics 756 767 .
Russell A. Wilke, Debbie W. Lin, Dan M. Roden, Paul B. Watkins, David Flockhart, Issam Zineh, Kathleen M. Giacomini & Ronald M. Krauss. (2007) Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges. Nature Reviews Drug Discovery 6:11, pages 904-916.
Crossref
Todd G. Nick & Kathleen M. Campbell. 2007. Topics in Biostatistics. Topics in Biostatistics 273 301 .
Federico InnocentiMark J Ratain. (2006) Pharmacogenetics of irinotecan: clinical perspectives on the utility of genotyping. Pharmacogenomics 7:8, pages 1211-1221.
Crossref
Steven Gutman & Larry G. Kessler. (2006) The US Food and Drug Administration perspective on cancer biomarker development. Nature Reviews Cancer 6:7, pages 565-571.
Crossref
Ansar Jawaid, Rachael Moore, Ruth March & Bryan J. Barratt. (2006) Gene mapping strategies for complex disease and drug response. Drug Discovery Today: Technologies 3:2, pages 131-136.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.